Moderna and U.S. at Odds Over Vaccine Patent Rights

WASHINGTON — Moderna and the National Institutes of Health are in a bitter dispute over who deserves credit for inventing the central component of the company’s powerful coronavirus vaccine, a conflict that has broad implications for the vaccine’s long-term distribution and billions of dollars in future profits.

The vaccine grew out of a…

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Shooting Witness Who Warned Rittenhouse Not To ‘Look For Trouble’ Skeptical About Murder Case Against Him

Pedestrian rushed to hospital after being hit by Met police car near Westfield in west London